Matrix Biomarkers and Mortality Risk in Elderly Men
Author Information
Author(s): Jonas Hansson, Ramachandran S. Vasan, Johan Ärnlöv, Erik Ingelsson, Lars Lind, Anders Larsson, Karl Michaëlsson, Johan Sundström
Primary Institution: Uppsala University, Uppsala, Sweden
Hypothesis
We investigated relations of serum levels of MMP-9 and TIMP-1 to mortality risk from an etiological perspective.
Conclusion
Higher levels of circulating MMP-9 and TIMP-1 are associated with increased mortality risk, particularly cardiovascular mortality and stroke risk.
Supporting Evidence
- Serum MMP-9 and TIMP-1 levels were associated with risk of all-cause mortality.
- TIMP-1 levels were mainly related to risks of cardiovascular mortality and stroke.
- All relations except those of TIMP-1 to stroke risk were attenuated by adjustment for cardiovascular disease risk factors.
Takeaway
This study found that higher amounts of certain proteins in the blood can mean a higher chance of dying, especially from heart problems or strokes.
Methodology
The study used a prospective cohort design, following 1,082 elderly men for up to 18.1 years, measuring serum levels of MMP-9 and TIMP-1 and analyzing their relation to mortality risk.
Potential Biases
Possible pre-analytical errors in measuring biomarkers and misclassification of causes of death.
Limitations
The study only included elderly men, limiting generalizability to women and younger populations.
Participant Demographics
1,082 elderly men, average age 71 years.
Statistical Information
Confidence Interval
95% CI 1.03–1.19 for MMP-9; 95% CI 1.02–1.20 for TIMP-1
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website